Weekly seroconversion rate of the mRNA-1273 SARS-CoV-2 vaccine in haemodialysis patients

Authors:

Abstract
Dialysis-dependent chronic kidney disease (DD-CKD) patients have a deficient immune response that predisposes them to infections and an inadequate response to vaccinations [ 1]. In addition, they have a higher risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in haemodialysis units, and once infected, they show greater mortality rates and longer hospital stays than the general population [ 2]. Moreover, this population’s seroconversion durability remains unknown, as antibody titers have been shown to decline with time [ 3], predisposing patients to potentially severe reinfections [ 4]. Therefore, some authors suggest that DD-CKD patients require close monitoring of post-vaccination seroconversion to determine optimal immunization schedules [ 5].

This publication has 12 references indexed in Scilit: